BN

Bhola Nath Nandi

Active Director Director DIN 02056770
DIN 02056770 First appointment Feb 2008 Primary industry Consumer Goods
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Feb 2008
Shareholding value •••• Premium profile

About Bhola Nath Nandi

Data last updated:

Bhola Nath Nandi is a Director at Med Biogenex Private Limited (since 2019), Director at Kanoria Infrastructure Private Limited (since 2014) and Director at Vamara Estates Private Limited (since 2025). The companies operate in Consumer Goods, Real Estate and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹1.18 Cr; the largest is Med Biogenex Private Limited at ₹1.11 Cr (FY 2025). Earlier, Bhola Nath Nandi was a Director at Life Labs Private Limited (2018–2024) and Additional Director at Gena Pharmaceuticals Limited (2011–2013) and 2 more.

DIN 02056770
Primary Designation Director
Industry Consumer Goods
First Appointment 25 Feb 2008
Oldest Company Age 21 yrs
Largest company Med Biogenex Private Limited · ₹1.11 Cr (FY 2025)
Combined revenue ₹1.18 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Med Biogenex Private Limited U74999WB2012PTC184011
Director06 Dec 20192012₹1.11 Cr (FY 2025)Active
Director06 Oct 20142005₹7.2 Lakh (FY 2025)Active
Vamara Estates Private Limited U68100UT2025PTC019446
Director20 Jun 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Life Labs Private Limited U74999WB2010PTC156158
Director14 Jun 20182010₹18.7 Lakh (FY 2025)Active
Gena Pharmaceuticals Limited U24239WB2004PLC098504
Additional Director30 Sep 20112004₹7.07 Cr (FY 2020)Under Liquidation
Director25 Feb 20081992₹1.43 Cr (FY 2024)Active
Gena Marketing Private Limited U65923WB1983PTC036747
Additional Director12 Jun 20121983₹9.7 Lakh (FY 2017)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Bhola Nath Nandi

Directorship timeline

Open interactive timeline →
Kanoria Infrastructure Private Limited
Med Biogenex Private Limited
Vamara Estates Private Limited
Life Labs Private Limited
Premium access

Shareholding and investment profile for Bhola Nath Nandi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhola Nath Nandi

Bhola Nath Nandi currently holds 3 directorships: Med Biogenex Private Limited (Director, since 06 Dec 2019, revenue ₹1.11 Cr (FY 2025)); Kanoria Infrastructure Private Limited (Director, since 06 Oct 2014, revenue ₹7.2 Lakh (FY 2025)); Vamara Estates Private Limited (Director, since 20 Jun 2025).

Bhola Nath Nandi was first appointed on 25 Feb 2008 as Director at Dalal Street Securities Private Limited. The most recent appointment on record is 20 Jun 2025 at Vamara Estates Private Limited.

The 2 current companies of Bhola Nath Nandi that report revenue have a combined latest revenue of ₹1.18 Cr: Med Biogenex Private Limited ₹1.11 Cr (FY 2025); Kanoria Infrastructure Private Limited ₹7.2 Lakh (FY 2025).

Bhola Nath Nandi held 4 earlier board appointments: Life Labs Private Limited (Director, 14 Jun 2018 to 15 Jul 2024); Gena Pharmaceuticals Limited (Additional Director, 30 Sep 2011 to 06 Mar 2013); Dalal Street Securities Private Limited (Director, 25 Feb 2008 to 01 Apr 2013); Gena Marketing Private Limited (Additional Director, 12 Jun 2012 to 06 Mar 2013).

The current boards of Bhola Nath Nandi's companies include Partha Protim Shaw (Med Biogenex Private Limited), Nisha Kanoria (Kanoria Infrastructure Private Limited), Arup Mukherjee (Vamara Estates Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available